Rifampicin-resistant Tuberculosis
📧 Sign up to get email alerts when something new happens for Rifampicin-resistant Tuberculosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-09-30Clinical Trial Update: 6 Months of Bedaquiline(BDQ), Delamanid(DLM), Linezolid(LZD) and Levofloxacin(LFX) in RR-TB Patients in Hubei Province [NA]
A clinical trial is evaluating a 6-month regimen using bedaquiline, delamanid, linezolid, and levofloxacin in rifampicin-resistant tuberculo…
-
CLINICAL_TRIALS trial_result · 2025-02-18Clinical Trial Update: GeneXpert Performance Evaluation for Linkage to Tuberculosis Care [NA]
Clinical trial update reporting results of evaluating GeneXpert performance for linkage to tuberculosis care, including pulmonary TB and rif…
-
CLINICAL_TRIALS trial_result · 2024-08-28Clinical Trial Update: Building Evidence for Advancing New Treatment for Rifampicin Resistant Tuberculosis (RR-TB) Comparing a Short Course of Treatment (Containing Bedaquiline, Delamanid and Linezolid) With the Current South African Standard of Care [Phase 3]
Phase 3 trial evaluating a short-course regimen containing bedaquiline, delamanid, and linezolid versus the current standard of care for rif…
-
CLINICAL_TRIALS trial_result · 2017-02-14Clinical Trial Update: Line Probe Assay Evaluation Study
This clinical trial update reports completion of a study evaluating the performance of a line probe assay for detecting drug resistance in t…